DALLAS INDUSTRY

Dallas Healthcare

Mangoceuticals Subsidiary Secured $2.5 Million Funding

Mangoceuticals Subsidiary Secured $2.5 Million Funding

Dallas-based Mangoceuticals raised capital for its IP subsidiary by selling membership interests instead of stock.

Live Poll

Do you trust that subsidiary-level deals protect public shareholders from stock dilution?


Recent news